The metabolomic quest for a biomarker in chronic kidney disease

Research output: Contribution to journalLiterature review

1 Citation (Scopus)
8 Downloads (Pure)

Abstract

Chronic kidney disease (CKD) is a growing burden on people and on healthcare for which the diagnostics are neither disease-specific nor indicative of progression. Biomarkers are sought to enable clinicians to offer more appropriate patient-centred treatments, which could come to fruition by using a metabolomics approach. This mini-review highlights the current literature of metabolomics and CKD, and suggests additional factors that need to be considered in this quest for a biomarker, namely the diet and the gut microbiome, for more meaningful advances to be made.
Original languageEnglish
Pages (from-to)694-703
Number of pages11
JournalClinical Kidney Journal
Volume11
Issue number5
Early online date2 Jun 2018
DOIs
Publication statusPublished - Oct 2018
Externally publishedYes

Fingerprint

Metabolomics
Biomarkers
Chronic Renal Insufficiency
Nutrition
Diet
Delivery of Health Care
Therapeutics
Gastrointestinal Microbiome

Bibliographical note

© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

Keywords

  • Metabolomics
  • Biomarkers
  • Diet
  • Chronic kidney disease

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Health Professions(all)

Cite this

The metabolomic quest for a biomarker in chronic kidney disease. / Davies, Robert.

In: Clinical Kidney Journal , Vol. 11, No. 5, 10.2018, p. 694-703.

Research output: Contribution to journalLiterature review

@article{d00ab3b3c6f6452b895b164c2a24a1bc,
title = "The metabolomic quest for a biomarker in chronic kidney disease",
abstract = "Chronic kidney disease (CKD) is a growing burden on people and on healthcare for which the diagnostics are neither disease-specific nor indicative of progression. Biomarkers are sought to enable clinicians to offer more appropriate patient-centred treatments, which could come to fruition by using a metabolomics approach. This mini-review highlights the current literature of metabolomics and CKD, and suggests additional factors that need to be considered in this quest for a biomarker, namely the diet and the gut microbiome, for more meaningful advances to be made.",
keywords = "Metabolomics, Biomarkers, Diet, Chronic kidney disease",
author = "Robert Davies",
note = "{\circledC} The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com",
year = "2018",
month = "10",
doi = "10.1093/ckj/sfy037",
language = "English",
volume = "11",
pages = "694--703",
journal = "CKJ: Clinical Kidney Journal",
issn = "2048-8505",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - The metabolomic quest for a biomarker in chronic kidney disease

AU - Davies, Robert

N1 - © The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PY - 2018/10

Y1 - 2018/10

N2 - Chronic kidney disease (CKD) is a growing burden on people and on healthcare for which the diagnostics are neither disease-specific nor indicative of progression. Biomarkers are sought to enable clinicians to offer more appropriate patient-centred treatments, which could come to fruition by using a metabolomics approach. This mini-review highlights the current literature of metabolomics and CKD, and suggests additional factors that need to be considered in this quest for a biomarker, namely the diet and the gut microbiome, for more meaningful advances to be made.

AB - Chronic kidney disease (CKD) is a growing burden on people and on healthcare for which the diagnostics are neither disease-specific nor indicative of progression. Biomarkers are sought to enable clinicians to offer more appropriate patient-centred treatments, which could come to fruition by using a metabolomics approach. This mini-review highlights the current literature of metabolomics and CKD, and suggests additional factors that need to be considered in this quest for a biomarker, namely the diet and the gut microbiome, for more meaningful advances to be made.

KW - Metabolomics

KW - Biomarkers

KW - Diet

KW - Chronic kidney disease

U2 - 10.1093/ckj/sfy037

DO - 10.1093/ckj/sfy037

M3 - Literature review

VL - 11

SP - 694

EP - 703

JO - CKJ: Clinical Kidney Journal

JF - CKJ: Clinical Kidney Journal

SN - 2048-8505

IS - 5

ER -